Finance Watch: 2021 Nearing Record Funding Levels For Regenerative Medicine
In Flurry Of New VC Deals, Vigil Neuroscience Raises $90m
ARM counts $14.1bn in fundraising in the first half of 2021, up 35% from mid-year 2020. Also, Chinese mRNA players Abogen raises a $700m series C venture capital round, Pfizer prices a $1bn sustainability bond and while IPOs slow in the US, China and South Korea see new first-time offerings.
